Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Prev Med. 2014 Aug 27;69:95–107. doi: 10.1016/j.ypmed.2014.08.026

Table 7.

Moderator analyses on clinical outcomes

Moderator n k Hedges’ g (95% CI) p Q p I2 Index
EPHPP study quality 9367 10 0.07 0.794
Weak 0 0 NA
Moderate 499 5 0.102 [−0.070; 0.273] 0.246 1.43 0.838 0%
Strong 8868 5 0.078 [0.036; 0.120] <.001 0.68 0.954 0%

Study design 9367 10 NA
Non-equivalent pre-test-post-test control group 8389 2 0.077 [0.034; 0.120] <.001 0.00 0.989 0%
Pre-test post-test control group 978 8 0.099 [−0.025; 0.223] 0.117 2.07 0.956 0%

Tailoring 1086 8 NA
No tailoring 834 6 0.106 [−0.029; 0.241] 0.123 0.80 0.977 0%
Tailoring by socio-demo 0 0 NA
Tailoring by stages/needs 252 2 0.142 [−0.114; 0.398] 0.278 0.22 0.639 0%
Tailoring by socio-demo & stages/needs 0 0 NA

Theoretical foundation 9367 10 NA
None mentioned 119 1 0.221 [−0.140; 0.581] 0.230 NA
Clinical psychology approaches/theory-based methods 40 1 0.181 [−0.236; 0.599] 0.395 NA
Only behavioral prediction theory 8317 2 0.078 [0.035; 0.121] <.001 0.04 0.851 0%
Only game theory 0 0 NA
Both behavioral and game theory 891 6 0.066 [−0.070; 0.202] 0.339 1.28 0.937 0%

Implementation method 9367 10 0.15 0.700
Stand-alone 475 4 0.113 [−0.062; 0.287] 0.206 0.64 0.888 0%
Multi-component 8892 6 0.077 [0.036; 0.119] <.001 1.40 0.925 0%

n=combined sample size; k=number of studies; Hedges’ g (random effects); CI= confidence Interval; Q= homogeneity statistic (mixed effects); I2=Inconsistency, a second measure of heterogeneity; NA: not applicable